aktiia
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.
CALFREE uses input from optical sensors commonly found in smartwatches or commercial smartphones to collect blood pressure data.
This new infusion of cash brings the company's total funding to $28 million.
The platform provides patients and their physicians insights into blood pressure patterns that better inform the diagnosis and management of hypertension.
The company plans to use the money to go to market with the product.
aktiia, a Swiss startup that makes wristband continuous blood pressure monitoring devices, has just scored $4.1M in funding.